Furthermore, anti-CD3/anti-SLAMF7 engagement increased the frequency of CD8+ T cells from HNSCC-TDLN expressing CD107a compared to single CD3 activation, indicating a restoration of their cytotoxic function (Supplementary Figure S5A). This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.